Physician profile
Peyton D Baker
NPI 1861021339
$6,598.79
in general payments reported to CMS, 2019-2025
33 companies · $1,749 in 2025
The $1,749 reported for 2025 was more than what 88% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,213 · 2023: $1,157 · 2024: $2,480 · 2025: $1,749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,750 · Travel and Lodging: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,750.08 |
| Travel and Lodging | $635.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,837.18 | 2023-2025 | Prostep, Ortholoc 2 Lapifuse, Citrefix |
| Active Medical, LLC | $1,200.00 | 2022 | |
| Paratek Pharmaceuticals, INC. | $404.22 | 2024-2025 | Nuzyra |
| Averitas Pharma INC. | $391.18 | 2023-2025 | Qutenza |
| Amgen INC. | $234.59 | 2024-2025 | Krystexxa, Otezla |
| Kerecis Limited | $223.02 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Organogenesis INC. | $186.10 | 2024-2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Medtronic, INC. | $161.20 | 2025 | Abre |
| Lilly USA, LLC | $144.05 | 2023-2025 | Taltz, Mounjaro, Zepbound |
| Convatec INC. | $111.93 | 2024-2025 | |
| Depuy Synthes Sales INC. | $77.39 | 2024-2025 | Motoband |
| Smith+Nephew, INC. | $69.81 | 2024-2025 | Grafix Pl, Grafix, Pico 7 |
| Polynovo North America LLC | $68.31 | 2023-2024 | Novosorb Btm |
| Csl Behring | $51.46 | 2023-2024 | Kcentra |
| Flower Orthopedics Coporation | $38.74 | 2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $36.99 | 2023-2024 | |
| Midsouth Orthopedics INC. | $32.03 | 2023-2024 | |
| Boston Scientific Corporation | $31.79 | 2024 | Wavewriter Alpha Prime 16 |
| Vertex Pharmaceuticals Incorporated | $31.64 | 2025 | |
| Ucb, INC. | $26.83 | 2024 | Cimzia |
| Djo, LLC | $25.04 | 2024 | Cmf |
| Alexion Pharmaceuticals, INC. | $22.71 | 2024 | Ultomiris |
| Solventum Corporation | $22.34 | 2024 | Activ.A.C. |
| Actelion Pharmaceuticals US, INC. | $21.31 | 2024 | Opsumit, Uptravi |
| Abbvie INC. | $20.71 | 2025 | |
| Orthofix Medical, INC. | $19.72 | 2023 | Galaxy Fixation System, Truelok, Tl-Hex Truelok Hexapod System |
| Janssen Biotech, INC. | $19.27 | 2024 | Tremfya |
| Janssen Pharmaceuticals, INC | $18.80 | 2024 | Xarelto |
| United Therapeutics Corporation | $15.92 | 2024 | Tyvaso |
| Mimedx Group, INC. | $15.26 | 2025 | |
| Nevro Corp. | $13.18 | 2024 | Senza |
| Cashflow Solutions, LLC | $13.17 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Spr Therapeutics, INC | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peyton Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.